• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


0.1450 AUD 0.00000.00%

As of 20:06:34 ET on 07/31/2014.

Snapshot for Novogen Ltd (NRT)

Open: 0.1450 Day's Range: 0.1450 - 0.1450 Volume: 2,000
Previous Close: 0.1450 52wk Range: 0.1150 - 0.3950 1-Yr Rtn: -17.14%

Stock Chart for NRT

No chart data available.
  • NRT:AU 0.1450
  • 1D
  • 1M
  • 1Y
Interactive NRT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0249
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 24.44
Shares Outstanding (M) 168.56
30 Day Average Volume 263,461
Price/Book (mrq) 4.8807
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRT

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for NRT

Novogen Limited is a medical services company which develops and markets pharmaceutical products in Australia. The Company conducts clinical trials on medications which promote the prevention and treatment of common cancers and the reversal of immune depression. The Company also develops dietary supplements, hormonal imbalance drugs, anti-inflammatory and cardiovascular drugs.

Graham Edmund KellyChairman/CEO/FounderLionel MateoSecretary
More Company Profile & Key Executives for NRT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil